(Q27851406)

English

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

scientific article

Statements

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. (English)
1 reference
0 references
Jeffrey A Engelman
0 references
Kreshnik Zejnullahu
0 references
Youngchul Song
0 references
Courtney Hyland
0 references
Joon Oh Park
0 references
Neal Lindeman
0 references
Christopher-Michael Gale
0 references
Xiaojun Zhao
0 references
James Christensen
0 references
Takayuki Kosaka
0 references
Alison J Holmes
0 references
Andrew M Rogers
0 references
Tony Mok
0 references
Charles Lee
0 references
Bruce E Johnson
0 references
18 May 2007
0 references
0 references
316
0 references
1039-43
0 references
5827
0 references
0 references
0 references
0 references
0 references
0 references
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit